Group A streptococci (GAS) are highly specific human pathogens. Their eficient colonization and dissemination within the host lead to a spectrum of local and invasive infections, as well as infectious sequella, e.g., rheumatic heart disease, streptococcal toxic shock syndrome, and necrotic fasciitis. GAS surface M and M-like proteins are critical virulence factors of these organisms, and function through various mechanisms to allow effective infectivity in the host. One important such mechanism depends on the activation of the host fibrinolytic system by these bacteria, and M (e.g., M1) and M-like (e.g., PAM) proteins are essential for this function in large part through their ability to bind to host human plasminogen (hPg) directly (PAM), or, indirectly (M1), via fibrinogen (Fg)/fibrin (Fn). Through this overal mechanism, M and M-like proteins enhance the activation of Pg to the serine protease, plasmin (Pm), by bacterial or host Pg activators, thus creating a proteolytic bacterial microenvironment employed by GAS to catalyze degradation of fibrin, the extracellular matrix, and/or connective tissue, which then assists the spread of the bacteria. We will employ structural biochemistry, as well as bacterial and mammalian genetics, to understand the in vitro and in vivo mechanistic relationships between GAS proteins that mediate its virulence via the host fibrinolytic system, and their reliance on specific proteins of this system. Specifically, we propose three aims: 1. To study the relationships between structural domains within a M-like protein (PAM, from GAS strain AP53) and an M protein (M1, from GAS strain SF370) in their in vitro functioning using structural biochemical tools. Emphasis will be placed on establishing the correspondence between 1o and 2o structures in these proteins with hPg and/or Fg binding and activation of hPg by bacterial streptokinase (SK) and host activators. 2. To design and study variant AP53 strains with altered expression of PAM and SK in order to change the mechanism of assimilation of Pm on GAS, or to render GAS deficient in its capacity to activate hPg. The virulence of these mutated GAS strains, in a murine invasive skin infection model, wil be examined in mice with investigator imposed genetic alterations in the fibrinolytic system. 3. To employ a continual venous catheterization infusion method to administer hPg and mutants of hPg into Pg-/- mice to examine the roles of individual domains of hPg in its activation to Pm in GAS, and the roles of these variant Pgs in promoting AP53 virulence. The overall goal of this work is to mechanistically assess interactions of the bacteria and the host in activation of the fibrinolytic system, and their relationships to GAS pathogenicity. This wil alow the establishment of new paradigms for treatment of diseases associated with these infections.

Public Health Relevance

Group A streptococcal (GAS) infections affect >700M people annually worldwide, with ~18M of these considered severe, and another ~600K of invasive types with a fatality rate of ~30%. There are more than 200 strains of GAS that have been identified. Among the important GAS virulence mechanisms is their ability to subvert the host fibrinolytic system to benefit the dissemination of the bacteria by dissolving the fibrin matrix that encapsulates the bacteria. Also, activation of the fibrinolytic system potentially results in a cascade of matrx metalloproteinase activations, thus assisting bacterial metastasis into deep tissues, causing life-threating infections. We will study the mechanisms by which this occurs to potentially allow new strategies to be used to attenuate this group of morbid and oftentimes fatal diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL013423-40
Application #
8403677
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Link, Rebecca P
Project Start
1975-02-01
Project End
2015-12-31
Budget Start
2013-01-01
Budget End
2013-12-31
Support Year
40
Fiscal Year
2013
Total Cost
$374,228
Indirect Cost
$124,743
Name
University of Notre Dame
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
824910376
City
Notre Dame
State
IN
Country
United States
Zip Code
46556
Bao, Yunjuan; Liang, Zhong; Booyjzsen, Claire et al. (2014) Unique genomic arrangements in an invasive serotype M23 strain of Streptococcus pyogenes identify genes that induce hypervirulence. J Bacteriol 196:4089-102
Mayfield, Jeffrey A; Liang, Zhong; Agrahari, Garima et al. (2014) Mutations in the control of virulence sensor gene from Streptococcus pyogenes after infection in mice lead to clonal bacterial variants with altered gene regulatory activity and virulence. PLoS One 9:e100698
Zhang, Yueling; Mayfield, Jeffrey A; Ploplis, Victoria A et al. (2014) The ?-domain of cluster 2b streptokinase is a major determinant for the regulation of its plasminogen activation activity by cellular plasminogen receptors. Biochem Biophys Res Commun 444:595-8
Sanderson-Smith, Martina L; Zhang, Yueling; Ly, Diane et al. (2013) A key role for the urokinase plasminogen activator (uPA) in invasive Group A streptococcal infection. PLoS Pathog 9:e1003469
Zhang, Yueling; Liang, Zhong; Glinton, Kristofor et al. (2013) Functional differences between Streptococcus pyogenes cluster 1 and cluster 2b streptokinases are determined by their ?-domains. FEBS Lett 587:1304-9
Liang, Zhong; Zhang, Yueling; Agrahari, Garima et al. (2013) A natural inactivating mutation in the CovS component of the CovRS regulatory operon in a pattern D Streptococcal pyogenes strain influences virulence-associated genes. J Biol Chem 288:6561-73
Agrahari, Garima; Liang, Zhong; Mayfield, Jeffrey A et al. (2013) Complement-mediated opsonization of invasive group A Streptococcus pyogenes strain AP53 is regulated by the bacterial two-component cluster of virulence responder/sensor (CovRS) system. J Biol Chem 288:27494-504
Han, Jaena; Baik, Nagyung; Kim, Kee-Hwan et al. (2011) Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen. Blood 118:1653-62
Wang, Min; Zajicek, Jaroslav; Geiger, James H et al. (2010) Solution structure of the complex of VEK-30 and plasminogen kringle 2. J Struct Biol 169:349-59
Figuera-Losada, Mariana; Ranson, Marie; Sanderson-Smith, Martina L et al. (2010) Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM). Biochim Biophys Acta 1804:1342-9

Showing the most recent 10 out of 112 publications